Filing Details

Accession Number:
0001140361-14-018105
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-04-30 17:51:44
Reporting Period:
2014-04-28
Filing Date:
2014-04-30
Accepted Time:
2014-04-30 17:51:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479659 Kerry Flom C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-04-28 160 $42.20 0 No 4 S Direct
Common Stock Acquisiton 2014-04-29 2,500 $20.47 2,500 No 4 M Direct
Common Stock Disposition 2014-04-29 2,500 $42.39 0 No 4 S Direct
Common Stock Acquisiton 2014-04-29 1,463 $0.00 1,463 No 4 M Direct
Common Stock Disposition 2014-04-29 474 $42.14 989 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock option (right to buy) Disposition 2014-04-29 2,500 $0.00 2,500 $20.47
Common Stock Restricted Stock Units Disposition 2014-04-29 1,463 $0.00 1,463 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-04-29 No 4 M Direct
4,387 No 4 M Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 11, 2013.
  2. Represents the aggregate of sales effected on the same day at different prices.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $42.01 to $42.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Vesting of restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2013.
  5. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of on this line were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs.
  6. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.083% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
  7. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  8. 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.